Janus Krarup

This inventor holds 8 USPTO granted patents and 3 published patent applications and 4 EPO patents. Top assignee: Novo Nordisk Healthcare Ag. Active years: 2011-2020.

USPTO Granted Patents = 8 (Patent Applications = 3)

% Patents Active = 75.0

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 1.4

ph-index = 2

Forward Citations = 20(Granted Patents)

Company Filing History:

8 out of 88

Novo Nordisk Healthcare Ag

patents

Years Active: 2011-2020

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10851364 - Method of controlling a polypeptide modification reaction (2020-12-01),

2. 10047354 - Reduction of dimer content in factor VII polypeptide compositions by heat treatment (2018-08-14),

3. 9187549 - Reduction of the content of protein contaminants in compositions comprising a vitamin K-dependent protein of interest (2015-11-17),

4. 9023992 - Hydrophobic interaction chromatography purification of factor VII polypeptides (2015-05-05),

5. 8921530 - Method for the production of proteins (2014-12-30),

6. 8530630 - Method for the production of proteins (2013-09-10),

7. 8084587 - Method for the production of proteins (2011-12-27),

8. 7897734 - Method for the production of proteins (2011-03-01),

Title: Inventor Spotlight: Janus Krarup

Introduction

Janus Krarup is a renowned inventor based in Gentofte, Denmark, with a remarkable track record consisting of eight patents. His work primarily focuses on advancements in biochemistry, specifically related to polypeptides and their modifications. Krarup's innovative contributions have played a significant role in the pharmaceutical industry, highlighting the critical intersection of science and technology.

Latest Patents

Among his notable inventions, two recent patents stand out:

1. **Method of controlling a polypeptide modification reaction** - This invention pertains to a method of regulating the activation of human factor VII (FVII) to produce human factor VII(a) (FVII(a)). It also encompasses polypeptides obtainable via this modification reaction, as well as pharmaceutical compositions that include these polypeptides.

2. **Reduction of dimer content in factor VII polypeptide compositions by heat treatment** - This patent focuses on a method to decrease the content of dimers in Factor VII polypeptide compositions through a heat treatment process, enhancing the quality and efficacy of these compositions.

Career Highlights

Janus Krarup's career is marked by his commitment to innovation and excellence in the field of biochemistry. He currently works with Novo Nordisk Healthcare AG, a global leader in diabetes care and biopharmaceuticals. His work has significantly contributed to the development of therapies that improve patient outcomes and quality of life.

Collaborations

Throughout his career, Krarup has collaborated with esteemed colleagues, including Daniel E. Rasmussen and Egon Persson. These professional relationships have fostered a creative environment that encourages groundbreaking research and innovative solutions within the pharmaceutical sector.

Conclusion

Janus Krarup exemplifies the spirit of innovation that drives progress in today's scientific landscape. With his impressive portfolio of patents, he continues to influence the field of biochemistry significantly. His dedication, expertise, and collaborative efforts position him as a key figure in the advancement of pharmaceutical technologies.